Search alternatives:
linear decrease » linear increase (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
841
-
842
-
843
Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups.
Published 2025Subjects: -
844
-
845
-
846
-
847
Univariate and multivariate analysis of variables associated with good and poor responders to TFESI.
Published 2025Subjects: -
848
-
849
The serum concentrations of cytokines between good responders and poor responders to TFESI.
Published 2025Subjects: -
850
Demographic data and baseline characteristics between good and poor responders to TFESI.
Published 2025Subjects: -
851
-
852
-
853
<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate....
Published 2025“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
-
854
Survey-weighted association of flavonoids and six subclasses intake with MASLD.
Published 2025Subjects: -
855
-
856
-
857
-
858
-
859
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
-
860